Increased levels of free serotonin in plasma of symptomatic asthmatic patients

Annals of Allergy, Asthma and Immunology

Volumn 77, Issue 3, 1996, Pages 245-253

  Lechin, Fuad ^a,c   Van Der Dijs, Bertha ^a   Orozco, Beatriz ^c   Lechin, Marcel ^b   Lechin, Alex E ^b  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CATECHOLAMINE; DOPAMINE; HYDROCORTISONE; NORADRENALIN; SEROTONIN;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CHILD; CLINICAL PROTOCOL; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RATING SCALE; SEROTONIN BLOOD LEVEL; SPIROMETRY; SYMPTOMATOLOGY; THROMBOCYTE AGGREGATION;

EID: 0029763014     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63263-2     Document Type: Article

References (69)

1. Lechin F, van der Dijs B, Rada I, et al. Plasma neurotransmitters and cortisol in duodenal ulcer patients: role of stress. Dig Dis Sci 1990;35:1313-9.
2. Lechin F, van der Dijs B, Insausti CL, et al. Treatment of ulcerative colitis with clonidine. J Clin Pharmacol 1985; 25:219-26.
3. Lechin F, van der Dijs B, Lechin A, et al. Doxepin therapy for postprandial symptomatic hypoglycaemic patients: neurochemical, hormonal and metabolic disturbances. Clin Sci 1991;80: 373-84.
4. Lechin F, van der Dijs B, Amat J, et al. Pimozide therapy for trigeminal neuralgia. Arch Neurol 1989;46:960-3.
5. Lechin F, van der Dijs B, Vitelli-Florez G, et al. Psychoneuro-endocrinological and immunological parameters in cancer patients: involvement of stress and depression. Psychoneuroendocrinology 1990;15:435-51.
6. Lechin F, van der Dijs B. Physiological, clinical and therapeutical basis of a new hypothesis for headache. Headache 1980;20:77-83.
7. Lechin F, van der Dijs B, Baez-Lechin S, et al. Two types of irritable bowel syndrome: pathophysiologic and pharmacologic considerations. Arch Ven Farmacol Terap 1994;12:105-14.
8. Lechin F, van der Dijs B, Lechin ME, et al. Plasma neurotransmitters throughout an oral glucose tolerance test in non-depressed essential hypertension patients. Clin Exper Hypertension 1993;15:209-40.
9. Lechin F, van der Dijs B, Lechin AE, et al. Plasma neurotransmitters and cortisol in chronic illness: role of stress. J Med 1994;25:181-92.
10. Lechin F, van der Dijs B, Jackubowicz D, et al. Role of stress in the exacerbation of chronic illness: effects of clonidine administration on blood pressure and plasma norepinephrine, cortisol, growth hormone and prolactin concentrations. Psychoneuroendocrinology 1987;12:117-29.
11. Lechin F, van der Dijs B, Lechin M, et al. Dramatic improvement with clonidine in acute pancreatitis with elevated catecholamine and cortisol plasma levels: report of five cases. J Med 1992;23:339-51.
12. Lechin AE, Varon J, van der Dijs B, Lechin F. Plasma catecholamines and indoleamines during attacks and remission on severe bronchial asthma: possible role of stress [Abstract]. Am J Respir Crit Care Med 1994;149:A778.
13. American Thoracic Society. Standard for diagnosis and care of patients with chronic obstructive disease (COPD) and asthma. Am Rev Respir Dis 1987; 136:225-45.
14. Hargreave FE, Dolovich J, Newhouse MT. The assessment and treatment of asthma: A conference report. J Allergy Clin Immunol 1990;85:1098-111.
15. Dickman ML, Schmidt CD, Gardner RM. Spirometric standards for normal children and adolescents (ages 5 years through 18 years). Am Rev Respir Dis 1971;104:680-7.
16. Davies CL, Molyneux SG. Routine determination of plasma catecholamines using reversed phase ion pair high performance liquid chromatography with electrochemical detection. J Chromatogr 1982;231:41-51.
17. Picard M, Olichon D, Gombert J. Determination of serotonin in plasma by liquid chromatography with electrochemical detection. J Chromatogr 1985;341:445-51.
18. Eisenhofer G, Goldstein DS, Stull R. Simultaneous liquid chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma and their responses to inhibition of monamine oxidase. Clin Chem 1986; 32:2030-3.
19. Murphy BEP. Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radio-assay. J Clin Endocr Metab 1967;27:973-90.
20. Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962;194:927-9.
21. Lechin F, van der Dijs B, Lechin M, et al. Effects of an oral glucose load on plasma neurotransmitters in humans: involvement of REM sleep? Neuropsychobiology 1992;26:4-11.
22. Haft JI, Arkel YS. Effect of emotional stress on platelet aggregation in humans. Chest 1976;70:501-5.
23. Larson PT, Hjemdahl P, Olsson G, et al. Altered platelet function during mental stress and adrenaline infusion in humans: evidence for an increase aggregability in vivo as measured by filtragometry. Clin Sci 1989;76: 369-76.
24. Anderson GM, Stevenson JM, Cohen DJ. Steady state model for plasma free and platelet serotonin in man. Life Sci 1987;41:1777-85.
25. Malmgren R, Grubbstrom J, Olsson P, et al. Defective serotonin (5HT) transport mechanism in platelets from patients with endogenous and allergic asthma. Allergy 1982;37:29-39.
26. Kjellstrom T, Ahlman H, Dahlstrom A, Risberg B. The cellular uptake in the rat lung in vivo - a histochemical study. Acta Physiol Scand 1982;116: 455-60.
27. Aas P. Serotonin induced release of acetylcholine from neurons in the bronchial smooth muscle of the rat. Acta Physiol Scand 1983;117:477-80.
28. Glusa E, Richter M. Endothelium-dependent relaxation of porcine pulmonary arteries via 5HT1C-like receptors. Naunyn-Schmiedeberg's Arch Pharmacol 1993;347:471-7.
29. Leff P, Martin GR, Morse JM. Differential classification of vascular smooth muscle and endothelial cell 5HT receptors by use of tryptamine analogues. Br J Pharmacol 1987;91:3231.
30. Lucchelli A, Santagostino-Barbone MG, Barbieri A, Tonini MA. A pharmacological analysis of receptors mediating the excitatory response to 5-hydroxytryptamine in the guinea pig isolated trachea. Br J Pharmacol 1994; 112:763-8.
31. Baumgartner RA, Wills-Karp M, Kaufman MJ, et al. Serotonin induces constriction and relaxation of the guinea pig airway. J Pharmacol Exp Ther 1990;255:165-73.
32. Dixon M, Jackson DM, Richards IM. The effects of 5-hydroxy-tryptamine, histamine and acetylcholine on the reactivity of the lung of the anesthetized dog. J Physiol 1980;307:85-96.
33. Feniuk W, Humphrey PPA. Mechanisms of 5-hydroxytryptamine-induced vasoconstriction. In: Fozard JR, ed. The peripheral actions of 5-hydroxytryptamine. Oxford: Oxford Medical Publications, 1989:100-22.
34. Islam MD, Melville GN, Ulmer WT. Role of atropine in antagonizing the effects of 5-hydroxytryptamine (5HT) on bronchial and pulmonary vascular systems. Respiration 1974;31:47-50.
35. Macquin-Mavier L, Jarreau PH, Istin N, Harf A. 5-hydroxytryptamine-induced bronchoconstriction in the guinea pig: effect of 5HT2 receptor activation on acetylcholine release. Br J Pharmacol 1991;102:1003-7.
36. Rizzo AC, Kreutner W, Chapman RW. 5HT3 receptors augment neuronal cholinergic contractions in guinea pig trachea. Eur J Pharmacol 1993;234: 109-12.
37. Sheller JR, Holtzman MF, Skoogh BE, Nadel JA. Interaction of serotonin with vagal- and ACh-induced bronchoconstriction in canine lungs. J Appl Physiol 1982;52:964-6.
38. Van Oosterhout AJM, Hofman G, van Kunanten W, Nijkamp FP. 5HT1 receptors mediate potentiation of cholinergic nerve-mediated contraction of isolated mouse trachea. Eur J Pharmacol 1991;209:237-44.
39. Hay M, Bishop VS. Effects of area postrema stimulation on neurons of the nucleus solitary tract. Am J Physiol 1991;260(Heart Circ Physiol 29): H1359-64.
40. Reynolds DJM, Leslie RA, Grahame-Smith DG, Harvey JM. Localization of 5HT3 receptor binding sites in human dorsal vagal complex. Eur J Pharmacol 1989;174:127-30.
41. Hay M, Bishop VS. Interactions of area postrema and solitary tract in the nucleus tractus solitary. Am J Physiol 1991;260(Heart Circ Physiol 29)LH1466-73.
42. Ireland SJ, Tyers MB. Pharmacological characterization of 5-hydroxytryptamine-induced depolarization of the rat isolated vagus nerve. Br J Pharmacol 1987;90:229-38.
43. 2 receptors augment cholinergic nerve-mediated contraction of rat bronchi. Eur J Pharmacol 1993;231: 339-46.
44. Buckner CK, Dea D, Liberati N, Krell RD. A pharmacological examination of receptors mediating serotonin-induced bronchoconstriction in the anesthetized guinea pig. J Pharmacol Exp Ther 1991;257:26-33.
45. Marin MG. Update: pharmacology of airway secretion. Pharmacol Rev 1994;46:35-65.
46. Lechin F, van der Dijs B, Orozco B, et al. Plasma neurotransmitters, blood pressure, and heart rate during supine-resting, orthostasis, and moderate exercise conditions in major depressed patients. Biol Psychiatry 1995;38: 166-73.
47. Lechin F, van der Dijs B, Orozco B, et al. Plasma neurotransmitters, blood pressure, and heart rate during supine resting, orthostasis, and moderate exercise in dysthymic depressed patients. Biol Psychiatry 1995;37:884-91.
48. Lechin F, van der Dijs B, Lechin AE, et al. Plasma neurotransmitters, blood pressure, and heart rate during supine-resting, orthostasis, and moderate exercise stress in healthy humans before and after the parasympathetic blockade with atropine. Arch Ven Farmacol Terap (In press).
49. Vargafting BB, Lefort J, Wal F, et al. Non-steroidal antiinflammatory drugs if combined with antihistamine and antiserotonin agents interfere with the bronchial and platelet effects of "platelet activating factor" (PAF-acether). Eur J Pharmacol 1982;82:121-30.
50. Hahn HL, Wilson AG, Graf PD, et al. Interactions between serotonin and efferent vagus nerves in dog lungs. J Appl Physiol 1978;44:144-9.
51. Undem BJ. Asthma: physiology, immunopharmacology, and treatment. Holgate ST, ed. San Diego: Academic Press, 1993:275-85.
52. Cabanes LR, Weber SN, Matran R, et al. Bronchial hyperresponsiveness to methacoline in patients with impaired left ventricular function. N Engl J Med 1989;320:1317-22.
53. Persson CGA. Plasma exudation and asthma. Lung 1988;166:1-23.
54. Tokuyama K, Kuo H-P, Rohde JAL, et al. Neural control of goblet cell secretion in guinea pig airways. Am J Physiol 1990;259:L108-15.
55. Nemtsov V, Kachanova T, Fedoseev G, et al. Serotonin level and vascular disturbances in bronchial asthma [Abstract]. Chest 1994;106:1468.
56. Knox AJ, Campos-Gongora H, Wisniewski A, et al. Modification of bronchial reactivity by physiological concentration of plasma epinephrine. J Appl Physiol 1992;73:1004-7.
57. Larsson K, Carlens P, Bevegard S, Hjemdahl P. Sympathoadrenal responses to bronchoconstriction in asthma: an invasive and kinetic study of plasma catecholamines. Clin Sci 1995;88:439-46.
58. Garattini S, Valzelli L. Importance of serotonin in anaphylactic, allergic, and inflammatory reactions. In: Garattini S, Valzelli L, eds. Serotonin. Amsterdam: Elsevier Publishing Company, 1965:103-36.
59. Cazzola M, Assogna G, Lucchetti G, et al. Effect of ketanserin, a new blocking agent of the 5-HT2 receptor, on airway responsiveness in asthma. Allergy (Denmark) 1990;45:151-3.
60. Cazzola M, Matera MG, D'Amato G, Rossi F. Effects of serotonin on airways: recent developments. Allergy 1995;50:1-10.
61. Jonderko G, Kwiatek R, Bierowiec J, et al. Effect of joint administration of antagonists of serotonin, histamine, and acetylcholine on ventilatory disorders in asthma. Pol Tyg Lek (Poland) 1978;33:1219-21.
62. Bariffi F. Trends in the treatment of bronchial asthma. Clin Ter (Italy) 1975;73:505-21.
63. Eisner JW. Drugs used in allergic states and their mode of action. Semin Drug Treat 1973;2:367-77.
64. Beyer E. Studies on the histamine-, serotonin- and acetylcholine antagonism of dexamethasone21-isonicotinate. Arzneimittelforschung (Germany) 1968;18:1312-3.
65. Scarpa GL. Effects of decloxizine on clinical symptomatology, respiratory function and cutaneous reaction to serotonin in asthmatic patients. Acta Tuberc Pneumol Belg 1968;59:583-90.
66. Palma Carlos AG, Galvao Lucas J, Palma Carlos ML. The treatment of bronchial asthma with BP-400. Acta Allergol 1967;22:387-98.
67. Chachaj W, Malolepszy J, Randowa D, Suchnicka R. The effects of deseril inhalations on ventilatory disturbances in allergic bronchial asthma. Pol Med J 1970;9:886-90.
68. Tucci R, Resti M, Fontana R, et al. Gastroesophageal reflux and bronchial asthma: prevalence and effect of cisapride therapy. J Pediatr Gastroenterol Nutr 1993;17:265-70.
69. Nolan P, Phillips M, Williamson B. Cisapride and brittle asthma. Lancet 1990;2:1443.